drugset / Trial / NCT00696059

Humira in Rheumatoid Arthritis - Do Bone Erosions Heal?

NCT00696059

Phase 4 Completed 52 enrolled Hvidovre University Hospital Abbott · collab
NaSingle-groupOpen-labelTreatment

Summary

Studies on tumor necrosis factor alpha antagonist (anti-TNF) therapy in rheumatoid arthritis (RA) patients have found that erosive damage may "heal" in some RA patients treated with anti-TNF. Repeated examinations of adalimumab (Humira) treated RA patients, using computed tomography (CT), magnetic resonance imaging (MRI), ultrasonography (US) and radiography will allow detailed assessment of the extent of bone repair/healing during adalimumab (Humira) therapy.

Timeline

Start
2004-08
Primary completion
2007-07
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Adalimumab Monoclonal antibody 40 mg Subcutaneous

Indications